3-(2,6-Difluorophenyl)-1,2-oxazol-5-amine, 95%, 1g

Piperazine, 1-(6-bromo-3-pyridinyl)-, 95.0%, 25g

(2E)-1-(3-bromophenyl)-3-(4-tert-butylphenyl)prop-2-en-1-one, 95.0%, 10g

(S)-2-Aminomethyl-4-Boc-morpholine, 95.0%, 250mg

Methyl 5-fluoro-2-methoxyisonicotinate, 95.0%, 100mg

1-(2-(Methylamino)phenyl)ethanone, 95.0%, 1g

3-(3-Chlorophenyl)propionic acid, 98.0%, 1g

Flacon d'hybridation sans revêtement, Hauteur, 100 mm, 35 mm, 1 Pièce

4,6-dichloro-5-ethylpyrimidine, 95.0%, 25g

DI-TERT-BUTYL 2-CYANOPIPERAZINE-1,4-DICARBOXYLATE, 95.0%, 100mg

(2S,3S,4S,5R,6S)-6-{[4,6-dihydroxy-2-(4-hydroxyphenyl)-5-oxo-5H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 1g

2-(Prop-1-en-2-yl)aniline, 95.0%, 5g

1-Methyl-1H-1,2,3-triazole-4-carbaldehyde, 97%, 1g